IDEAS home Printed from https://ideas.repec.org/a/sae/clnure/v31y2022i4p588-597.html
   My bibliography  Save this article

Health-Related Quality of Life in the Spironolactone to Reduce ICD Therapy (SPIRIT) Trial

Author

Listed:
  • Ana C. S. Liberato
  • Merritt H. Raitt
  • Ignatius Gerardo E. Zarraga
  • Karen S. MacMurdy
  • Cynthia M. Dougherty

Abstract

To describe health related quality of life (HRQOL) and symptoms in the SPIRIT trial and determine effects of implantable cardioverter defibrillator (ICD) shocks on HRQOL over 24 months. Ninety participants aged 66 ± 10 years, 96% men, 75% with NYHA class II, with an ICD were randomized to spironolactone 25 mg ( N  = 44) or placebo ( N  = 46). HRQOL was measured every 6 months for 24 months using: Patient Concerns Assessment (PCA), Short Form Health Survey-Veterans Version (SF-36V), and Kansas City Cardiomyopathy Questionnaire (KCCQ). Linear mixed modeling compared changes in HRQOL over-time and ANCOVA compared HRQOL between those getting an ICD shock or not. Over 24-months, there were no differences in HRQOL between the spironolactone versus placebo groups. Those with at least one ICD shock reported significantly lower HRQOL and more symptoms at 6- and 24-months. Patients receiving one or more ICD shocks reported significant reductions in HRQOL and higher symptoms.

Suggested Citation

  • Ana C. S. Liberato & Merritt H. Raitt & Ignatius Gerardo E. Zarraga & Karen S. MacMurdy & Cynthia M. Dougherty, 2022. "Health-Related Quality of Life in the Spironolactone to Reduce ICD Therapy (SPIRIT) Trial," Clinical Nursing Research, , vol. 31(4), pages 588-597, May.
    • Handle: RePEc:sae:clnure:v:31:y:2022:i:4:p:588-597
    DOI: 10.1177/10547738211036817
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/10547738211036817
    Download Restriction: no
    File URL: https://libkey.io/10.1177/10547738211036817?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:clnure:v:31:y:2022:i:4:p:588-597. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.